(Q38589005)

4 September 2017

title

Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics (English)

1 reference

4 September 2017

1 reference

Ysabella Z A Van Sebille

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Romany Stansborough

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Hannah R. Wardill

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Emma Bateman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Rachel J. Gibson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

6

Dorothy M Keefe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

1 November 2015

1 reference

4 September 2017

published in

Current Oncology Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

The pathobiology of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Acute and long-term gastrointestinal consequences of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Chemotherapy-induced diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Gastrointestinal mucositis: a new biological model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Emerging evidence on the pathobiology of mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

The MASCC/ISOO mucositis guidelines: dissemination and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Gastrointestinal complications of oncologic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Inducing intestinal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Mitogenic influence of human R-spondin1 on the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Use of probiotics in the management of chemotherapy-induced diarrhea: a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Probiotic therapy in radiation-induced intestinal injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

A gastroenterologist's guide to probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

New pharmacotherapy options for chemotherapy-induced alimentary mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Miconazole mucoadhesive buccal tablet in high-dose therapy with autologous stem cell transplantation (HDT/ASCT)-induced mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

A comparison of dioctahedral smectite and iodine glycerin cream with topical mouth rinse in treatment of chemotherapy induced oral mucositis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in pat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Systematic review of agents for the management of gastrointestinal mucositis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Pilot Study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy-induced side-effects in acute myeloid leukaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

MuGard, an oral mucoadhesive hydrogel, reduces the signs and symptoms of oral mucositis in patients with lichen planus: a double-blind, randomized, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Treatment of oral mucositis pain following radiation therapy for head-and-neck cancer using a bioadhesive barrier-forming lipid solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Systematic review of natural agents for the management of oral mucositis in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double-blind randomized study in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

The prevention of induced oral mucositis with low-level laser therapy in bone marrow transplantation patients: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Low-energy laser therapy for prevention of oral mucositis in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: 2012 state of the art based on literature review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-015-0474-9

The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other rinsing solutions in patients with oral mucositis after allogeneic stem cells transplantation.

21 January 2018

1 reference

12 December 2020

The burdens of cancer therapy

1 reference

12 December 2020

A comparison between zinc sulfate and chlorhexidine gluconate mouthwashes in the prevention of chemotherapy-induced oral mucositis.

1 reference

12 December 2020

Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung

1 reference

12 December 2020

Oral mucositis in cancer therapy.

1 reference

12 December 2020

L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life

1 reference

12 December 2020

Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial

1 reference

12 December 2020

EphB receptors coordinate migration and proliferation in the intestinal stem cell niche

1 reference

12 December 2020

N-acetyl cysteine for prevention of oral mucositis in hematopoietic SCT: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Prevention and treatment of oral mucositis in patients with head and neck cancer treated with (chemo) radiation: report of an Italian survey

1 reference

12 December 2020

The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial

1 reference

12 December 2020

The Importance of Planned Dose of Chemotherapy on Time: Do We Need to Change Our Clinical Practice?

1 reference

12 December 2020

Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat.

1 reference

12 December 2020

A biological approach to mucositis

1 reference

12 December 2020

10.1007/S11912-015-0474-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 June 2020

1045243369

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26384312%20AND%20SRC:MED&resulttype=core&format=json